KI
VIVO

Koch Industries’s Meridian Bioscience Inc VIVO Stock Holding History

Koch Industries’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-12,529
Closed -$178K – 726
2018
Q1 		$178K Sell
12,529
-1,883
-13% -$27.9K 0.02% 825
2017
Q4 		$202K Buy
+14,412
New +$211K 0.03% 622
2017
Q2 		– Sell
-11,935
Closed -$165K – 576
2017
Q1 		$165K Buy
+11,935
New +$167K 0.14% 248

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Koch Industries's VIVO Position: Q2 2018 in Review

Koch Industries sold out of Meridian Bioscience Inc (VIVO) in Q2 2018, closing a stake of 12,529 shares — an estimated $178K sold.

Koch Industries first reported a position in VIVO in Q1 2017 and held it in 3 quarters. The position peaked at $202K in Q4 2017. 177 funds tracked by Wall St. Rank hold VIVO as of Q2 2018.

  • Koch Industries reported no remaining Meridian Bioscience Inc position as of Q2 2018 after selling out during the quarter.
  • Koch Industries sold 12,529 Meridian Bioscience Inc shares in Q2 2018, an estimated $178K.
  • Koch Industries first reported a position in Meridian Bioscience Inc in Q1 2017 and held it in 3 quarters.
  • Koch Industries's Meridian Bioscience Inc position peaked at $202K in Q4 2017.
  • 177 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2018.

Based on Koch Industries's 13F filing for Q2 2018, filed 13 Aug 2018.